彭质斌,王大燕,杨娟,杨鹏,张延炀,陈健,陈涛,郑亚明,郑建东,姜世强,徐莉立,康敏,秦颖,赵梦娇,李中杰,冯录召.中国流感疫苗应用现状及促进预防接种的政策探讨[J].Chinese journal of Epidemiology,2018,39(8):1045-1050 |
中国流感疫苗应用现状及促进预防接种的政策探讨 |
Current situation and related policies on the implementation and promotion of influenza vaccination, in China |
Received:May 31, 2018 |
DOI:10.3760/cma.j.issn.0254-6450.2018.08.007 |
KeyWord: 流感疫苗 预防接种 促进 政策建议 |
English Key Word: Influenza vaccine Vaccination Promotion Policy considerations |
FundProject: |
Author Name | Affiliation | E-mail | Peng Zhibin | Division of Infectious Disease, National Influenza Center Beijing 102206, China | | Wang Dayan | National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China | | Yang Juan | School of Public Health, Fudan University, Shanghai 200032, China | | Yang Peng | Beijing Center for Disease Control and Prevention, Beijing 100013, China | | Zhang Yanyang | Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China | | Chen Jian | Shanghai Center for Disease Control and Prevention, Shanghai 200336, China | | Chen Tao | National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China | | Zheng Yaming | Division of Infectious Disease, National Influenza Center Beijing 102206, China | | Zheng Jiandong | Division of Infectious Disease, National Influenza Center Beijing 102206, China | | Jiang Shiqiang | Nanshan District Center for Disease Control and Prevention, Shenzhen 518054, China | | Xu Lili | Qinghai Center for Disease Control and Prevention, Xining 810007, China | | Kang Min | Guangdong Center for Disease Control and Prevention, Guangzhou 511430, China | | Qin Ying | Division of Infectious Disease, National Influenza Center Beijing 102206, China | | Zhao Mengjiao | Division of Infectious Disease, National Influenza Center Beijing 102206, China | | Li Zhongjie | Division of Infectious Disease, National Influenza Center Beijing 102206, China | | Feng Luzhao | Division of Infectious Disease, National Influenza Center Beijing 102206, China | fenglz@chinacdc.cn |
|
Hits: 5917 |
Download times: 2778 |
Abstract: |
流感是一种疫苗可预防性疾病,每年接种流感疫苗是预防流感及其并发症的最有效手段。流感疫苗在我国是二类疫苗,年平均接种率仅2%~3%。接种率低的原因包括公众对流感和流感疫苗认知不足、医务人员极少推荐、接种服务可及性和费用等。为促进我国流感疫苗的预防接种,降低流感对公众的健康危害和经济负担,应考虑采取综合政策措施积极推动流感疫苗预防接种工作,包括采用不同筹资方式和机制,提高重点人群的接种意愿和接种率、改进免疫服务公平性的效果和效率;提高医务人员和公众对流感和疫苗预防的认识,改进临床预防实践,通过制订临床指南、路径、专家共识等多种渠道,推动临床医生对流感疫苗预防接种建议的推荐;加快预防接种工作体系建设,为公众提供更方便、可及和规范的预防接种;加大新型流感疫苗研发支持力度,加快新型流感疫苗上市应用;修订我国药典中"妊娠期妇女为流感疫苗接种禁忌"的条款。 |
English Abstract: |
Influenza can be prevented through annual appropriate vaccination against the virus concerned. In China, influenza vaccine is categorized as "Class Ⅱ" infectious diseases which the cost is paid out of the user's pockets. The annual coverage of influenza vaccination had been 2%-3%. The main reasons for the low coverage would include the following factors:lacking awareness on both the disease and vaccine, poor accessibility of vaccination service, and the cost of vaccination. To reduce the health and economic burden associated with influenza, comprehensive policies should be improved, targeting the coverage of seasonal influenza vaccination. These items would include:① Different financing reimbursement schemes and mechanisms to improve the aspiration on vaccination and on the vaccine coverage in high-risk groups, as young children, elderly, people with underlying medical conditions; ② to ameliorate equality of vaccination services; ③ to improve knowledge of the health care workers (HCWs) and the public on influenza and related vaccines; ④ to improve clinical and preventive medical practice and vaccination among HCWs through revising clinical guidelines, pathway and consensus of experts; ⑤ to provide more convenient, accessible and normative vaccination service system; ⑥ to strengthen research and development as well as marketing on novel influenza vaccines; ⑦ to revise items regarding the contraindication for influenza vaccine on pregnancy women, stated in the Chinese Pharmacopoeia. |
View Fulltext
Html FullText
View/Add Comment Download reader |
Close |
|
|
|